+499.5%
MRNA vs NTR
+43.1%
+456.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.7% | -2.0% |
| 7D | +5.5% | +8.1% | -2.6% | +4.4% |
| 30D | +158.7% | +18.8% | +140.0% | +154.5% |
| 3M | +182.1% | +16.2% | +165.9% | +178.1% |
| 6M | +151.8% | +9.8% | +142.1% | +146.7% |
| YTD | +393.6% | +30.9% | +362.7% | +367.7% |
| 1Y | +499.5% | +41.8% | +457.7% | +472.4% |
| All | +499.5% | +43.1% | +456.4% | +472.4% |
Cumulative growth
Daily Returns
Daily percentage return beside NTR.
Daily Out/Under-Performance
Portfolio return minus NTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling